OTCMKTS:TRLPF

Acerus Pharmaceuticals (TRLPF) Stock Price, News & Analysis

Acerus Pharmaceuticals logo
$0.22 0.00 (0.00%)
As of 07/21/2023

About Acerus Pharmaceuticals Stock (OTCMKTS:TRLPF)

Key Stats

Today's Range
$0.22
▼
$0.22
50-Day Range
$0.22
▼
$0.22
52-Week Range
$0.08
▼
$0.34
Volume
N/A
Average Volume
5,474 shs
Market Capitalization
$56.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Acerus Pharmaceuticals was a Canadian specialty pharmaceutical company focused on developing and commercializing prescription medicines, particularly in men’s health. The company was formerly known as Trimel Pharmaceuticals and adopted the Acerus name in 2015.

Its best-known product was Natesto, a testosterone nasal gel prescribed for adult men with testosterone deficiency. Acerus also pursued and commercialized other specialty pharmaceutical products, with business activities centered on markets in Canada and the United States.

In 2022, Acerus sought creditor protection under Canada’s Companies’ Creditors Arrangement Act. Its description as an operating pharmaceutical business is therefore historical.

AI Generated. May Contain Errors.

Receive TRLPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acerus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRLPF Stock News Headlines

Takeda Pharmaceutical Co. Ltd. ADR
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Acerus Reports Second Quarter 2022 Financial Results
See More Headlines

TRLPF Stock Analysis - Frequently Asked Questions

Acerus Pharmaceuticals' stock was trading at $0.22 at the beginning of 2026. Since then, TRLPF shares have increased by 0.0% and is now trading at $0.22.

Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF) posted its earnings results on Monday, November, 5th. The specialty pharmaceutical company reported ($0.01) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.01). The specialty pharmaceutical company earned $1.58 million during the quarter. Acerus Pharmaceuticals had a negative net margin of 254.66% and a negative trailing twelve-month return on equity of 346.72%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acerus Pharmaceuticals investors own include Acerus Pharmaceuticals (ASP), Alkermes (ALKS), Applied Materials (AMAT), American Financial Group (AFG), Algonquin Power & Utilities (AQN), Arcos Dorados (ARCO) and Aurora Cannabis (ACBFF).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:TRLPF
CIK
N/A
Fax
N/A
Employees
29
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($0.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.79 million
Net Margins
-254.66%
Pretax Margin
N/A
Return on Equity
-346.72%
Return on Assets
-94.54%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.35
Quick Ratio
0.90

Sales & Book Value

Annual Sales
$7.38 million
Price / Sales
7.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
258,615,000
Free Float
N/A
Market Cap
$56.90 million
Optionable
Not Optionable
Beta
2.60

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:TRLPF) was last updated on 7/21/2023 by MarketBeat.com Staff.
From Our Partners